nsc20262

Inosine (NSC-20262), an endogenous purine nucleoside produced by the catabolism of adenosine, is an agonist of adenosine receptors A1R and A2AR. Inosine has anti-inflammatory, immunomodulatory, antinociceptive and neuroprotective effects.

Inosine-15N4 is the 15N-labeled version of Inosine (TMSM-1368).

Inosine-13C5 is an isotope of Inosine (TMSM-1368), marked with the label 13C5.

Inosine (Standard) is a reference standard for inosine, suitable for quantitative analysis, quality control, and biochemical experiments. Inosine is an endogenous purine nucleoside produced by the catabolism of adenosine. It acts as an agonist for adenosine receptors and can be used in studies of inflammation, immunity, and neuroprotection.

Inosine-[1‘.2‘.3‘.4‘.5‘-13C5] (Standard) is a reference standard of Inosine-[1‘.2‘.3‘.4‘.5‘-13C5] intended for quantitative analysis, quality control, and related biochemical research applications.

Inosine-2,8-D2 is the deuterated form of Inosine. Inosine (T0437) is an endogenous purine nucleoside produced from the metabolism of adenosine. It exhibits anti-inflammatory and immunomodulatory properties, as well as analgesic and neuroprotective effects. Additionally, Inosine (T0437) acts as an agonist at adenosine receptors A1R and A2AR.